Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2198]

Genomic profiling of penile squamous cell carcinoma reveals major biomarkers...

Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy

Genomic profiling of penile squamous cell carcinoma reveals major biomarkers for efficacy of immunotherapy ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )

Pembrolizumab shows notable antitumour activity for patients with high-risk...

Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy

Pembrolizumab shows notable antitumour activity for patients with high-risk non–muscle-invasive bladder cancer ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )

Plasma miR371 detects MRD and early relapse of germ cell tumours

Dr Lucia Nappi - University of British Columbia, Vancouver, Canada

Plasma miR371 detects MRD and early relapse of germ cell tumours ( Dr Lucia Nappi - University of British Columbia, Vancouver, Canada )

Adaptive image-guided radiotherapy in muscle-invasive bladder cancer shows low...

Prof Robert A Huddart - Royal Marsden NHS Foundation Trust, London, UK

Adaptive image-guided radiotherapy in muscle-invasive bladder cancer shows low toxicity and good outcomes ( Prof Robert A Huddart - Royal Marsden NHS Foundation Trust, London, UK )

Cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in...

Dr Laurence Albiges - Institut Gustave Roussy, Villejuif, France

Cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced RCC ( Dr Laurence Albiges - Institut Gustave Roussy, Villejuif, France )

Final OS results of IMvigor130: Atezolizumab plus platinum/gemcitabine for mUC

Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA

Final OS results of IMvigor130: Atezolizumab plus platinum/gemcitabine for mUC ( Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA )

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in...

Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients ( Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA )

Adjuvant nivolumab as standard of care for high-risk muscle-invasive urothelial...

Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA

Adjuvant nivolumab as standard of care for high-risk muscle-invasive urothelial carcinoma after radical resection ( Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA )

Erdafitinib demonstrates efficacy in intermediate-risk non–muscle-invasive...

Prof Siamak Daneshmand - University of Southern California, Los Angeles, USA

Erdafitinib demonstrates efficacy in intermediate-risk non–muscle-invasive bladder cancer with FGFR alterations ( Prof Siamak Daneshmand - University of Southern California, Los Angeles, USA )

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer

Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer ( Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain )

L'importance de choisir judicieusement en oncologie chirurgicale

Prof Sidy Ka - Cheikh Anta Diop University, Dakar, Senegal

L'importance de choisir judicieusement en oncologie chirurgicale ( Prof Sidy Ka - Cheikh Anta Diop University, Dakar, Senegal )

Etat des lieux de la lutte contre le cancer au Sénégal: investissons-nous à bon...

Prof Sidy Ka - Cheikh Anta Diop University, Dakar, Senegal

Etat des lieux de la lutte contre le cancer au Sénégal: investissons-nous à bon escient dans les spécialistes locaux? ( Prof Sidy Ka - Cheikh Anta Diop University, Dakar, Senegal )

More from ecancer